SYSTEM NOTICE

Auto translation by AI. Be sure, accuracy, nuances and authorial intent may not be fully reflected.
見出し画像

Veralto (VLTO) vs. Xylem (XYL) — A Thorough Comparison of Business Growth Potential


[Comprehensive Water Power — Veralto: "Measure and Protect," Xylem: "Transport and Treat"]

Record Date: July 18, 2026
Stock Price: Veralto approx. $91.5 (NYSE) / Xylem approx. $121.4 (NYSE)

* Both companies are USD-denominated, NYSE-listed, have December fiscal year-ends, and use US GAAP, making them a convenient combination for comparison. However, stock prices are reference values as of the record date.
* Veralto is a company that spun off from the industrial conglomerate Danaher in October 2023. While it may appear to be a "new company" with a short history, the brands under its umbrella have long histories.


Author's Key Points

  • Attention Level: Veralto ★★★☆☆ / Xylem ★★☆☆☆

  • I am somewhat interested in Veralto's 'high capital efficiency and profit margins.' However, this is largely due to differences in the nature of their businesses, and the depth of water infrastructure and business scale is clearly superior in Xylem. This is not a discussion of which is superior, but rather how to read them as two different ways of engaging with the common theme of "water."


1. Current Stock Price and Valuation Comparison

Veralto (VLTO, NYSE)

  • Stock Price: approx. $91.5

  • Market Capitalization: approx. $22 billion

  • P/E Ratio: Trailing approx. 23.5x / Forward approx. 21.1x

  • ROE: approx. 36.5% (very high)

  • Dividend Yield: approx. 0.6% (annual dividend $0.52, payout ratio is low at approx. 12%)

  • P/B Ratio: High level (the price-to-book ratio tends to appear high because equity is relatively thin due to goodwill, etc., associated with the spin-off)

Xylem (XYL, NYSE)

  • Stock Price: approx. $121.4

  • Market Capitalization: approx. $28.9 billion

  • P/E Ratio: Trailing approx. 29-30x / Forward approx. 21x

  • ROE: approx. 8.7%

  • Dividend Yield: Approximately 1.4% (Annual dividend of $1.72, Q1 dividend up 8% year-over-year)

  • PBR: Approximately 2.4x

What stands out here is the difference in ROE. Veralto's ROE of approximately 36% is largely due to structural factors where equity is thin following its spin-off, while Xylem's ROE of approximately 9% is impacted by the assets and goodwill that expanded following the Evoqua acquisition (discussed later). It is important to note that this is not a simple matter of superiority or inferiority, but rather a reflection of the differences in their balance sheet structures in the figures.

② Comparison of Recent Financial Results

Veralto (Q1 2026)

  • Revenue: $1.422 billion (+6.7% year-over-year)

  • Net Income: $254 million

  • Diluted EPS: $1.02 (Previous year: $0.90)

  • Full-year 2026 Guidance: Raised adjusted EPS to $4.20–$4.28

Xylem (Q1 2026)

  • Revenue: $2.125 billion (+3% year-over-year)

  • Adjusted EPS: $1.12 (+9%)

  • Orders: $2.2 billion

  • Full-year 2026 Guidance: Revenue of $9.2–$9.3 billion, adjusted EPS of $5.35–$5.60, adjusted EBITDA margin of 22.9–23.3%

Source: Both companies' Q1 2026 financial results (Veralto Q1 2026, Xylem Q1 2026). *Full-year 2025 revenue was approximately $5.5 billion for Veralto and approximately $9.0 billion for Xylem. In terms of scale, Xylem is approximately 1.6 times larger. Xylem's next earnings release (Q2) is scheduled for July 28, 2026.

③ Comparison of Business Structure and Mid-term Plans

Veralto: Two-segment structure

  • Water Quality (WQ): The core of revenue. Water quality analysis, disinfection, and treatment for water/wastewater and industrial applications. Key brands include Hach, Trojan Technologies, and ChemTreat. Q1 2026 saw high growth at +10.1%.

  • Product Quality & Innovation (PQI): Marking/coding and color management for food, pharmaceuticals, and packaging. Key brands include Videojet, Esko, X-Rite, and Pantone. Q1 was somewhat sluggish at +1.7%.

  • Strengths: High profit margins (adjusted operating margin in the mid-20s), capital efficiency, and stable revenue from consumables and services.

  • Challenge: PQI (Product Quality & Identification) is susceptible to economic and capital expenditure fluctuations, and growth has been sluggish recently.

  • Recent developments: Acquired In-Situ (approx. $426 million, cash) in the water quality sector, and agreed to acquire GlobalVision (270 million CAD) for PQI.

Xylem: Four-segment structure

  • Water Infrastructure: Pumps, treatment equipment, etc., for water transport and treatment. Approx. $2.6 billion in 2025.

  • Applied Water: Pumps and systems for building, industrial, and agricultural use.

  • Measurement and Control Solutions: Smart meters and water digitalization.

  • Water Solutions and Services: Treatment and services centered on Evoqua, acquired in 2023.

  • Strengths: Overwhelming business scale and brand network in water infrastructure, tailwinds from public infrastructure investment and digitalization, and expansion of recurring revenue.

  • Challenge: Profit margins tend to lag behind competitors like Pentair. Currently in the process of improving profitability while managing the integration of large-scale acquisitions.

  • Recent developments: Set a $1.5 billion share buyback program in February 2026. Stated that the integration of Evoqua (approx. $7.5 billion, 2023) was completed 18 months ahead of schedule.

④ Differences in Business Strategy Between the Two Companies

  • Approach to Expanding Business Portfolio: Veralto focuses on two high-margin niche pillars: "Water Quality" and "Product Identification." Xylem employs a comprehensive strategy covering water from "inlet to outlet" (pumps, treatment, measurement, and services).

  • Investment Policy and Growth Method: Veralto follows a "Danaher-style" serial acquisition model, accumulating small-to-medium bolt-on acquisitions (In-Situ, GlobalVision). Xylem expanded its scope significantly with the large-scale Evoqua acquisition and is now focused on its integration and profitability improvement.

  • Direction of Market Development: Veralto focuses on "defensive" measures through consumables and analysis (water quality assurance and quality assurance). Xylem targets demand for "social infrastructure," such as public infrastructure renewal and digital measurement.

  • Structural Differences Resulting from Strategy: As a result, Veralto has a profile of high margins, high capital efficiency, and agility, while Xylem has a contrasting profile of large scale, stable demand, and close ties to infrastructure.

⑤ Market Size (TAM) and Growth Potential

*Market expansion does not directly translate into the performance or stock price of each company. Please view this only as a guide to the business environment.

  • Main Battlefield: Both companies operate primarily in the vast "water and wastewater treatment" market. According to Fortune Business Insights, the global water and wastewater treatment market is projected to be approximately $372.4 billion in 2025, $400.3 billion in 2026, and $714.0 billion in 2034 (global market, CAGR of approximately 7.5%).

  • From another perspective, BCC Research projects the water and wastewater treatment "technology" market to grow from approximately $350.7 billion in 2025 to approximately $591.2 billion by 2030 (a CAGR of about 11.0%). The figures vary significantly depending on the market definition (whether it includes only equipment or also services).

  • Growth Drivers: Replacement of aging infrastructure, tightening water quality regulations such as those for PFAS (per- and polyfluoroalkyl substances), water reuse and digitalization, and urbanization in emerging countries.

  • Restraining Factors: Public budgets and interest rate trends, delays in large-scale projects, and raw material costs.

  • Market Position: While Xylem is a top industry player (market cap of approximately $28.9 billion), Veralto (approximately $22.0 billion) has a strong presence in the field of water quality analysis. Regarding PFAS compliance, the division of roles is often described as "Veralto handles the analysis (measurement), while Xylem and Pentair provide the physical removal equipment."

⑥ Competitive Advantages and Barriers to Entry for Each Company

Veralto's Moat

  • Source of Competitive Advantage: Lock-in through analytical instruments like Hach, combined with dedicated reagents and consumables (a structure where once installed, customers continue to purchase consumables). Switching costs are high because these are directly linked to regulations and quality assurance.

  • Types of Barriers: Switching costs / Brand and reliability / Track record in regulatory compliance.

  • Sustainability: Strong. Water quality and quality assurance are areas where "mistakes are not an option," making it easy for proven brands to be consistently chosen.

Xylem's Moat

  • Source of Competitive Advantage: Overwhelming installed base in water infrastructure, extensive sales and service networks, long-standing relationships with public utilities, and data accumulation from smart metering.

  • Types of Barriers: Economies of scale / Customer base and channels / Service revenue tied to the installed base.

  • Sustainability: Medium to Strong. While stable due to its close ties to infrastructure, products like pumps are subject to commodity competition, and it can lag behind specialized firms like Pentair in terms of profit margins.

Which moat is deeper: They have different characteristics. Veralto has a highly sticky moat based on "consumables × regulations," while Xylem has a broad and stable moat based on "scale × infrastructure installed base." It is fair to conclude that the types of depth are different.

⑦ Business Environment Scenarios for the Next 3 Years

*This is merely an assessment of the business environment and not a stock price forecast.

  • Tailwind Scenario: Global investment in water infrastructure renewal and the full-scale implementation of PFAS regulations lead to simultaneous growth in demand for water quality analysis (Veralto) and treatment/measurement (Xylem). Both companies increase their profit margins through bolt-on acquisitions and pricing strategies.

  • Base Case Scenario: Low to mid-single-digit organic growth continues. Veralto sees strong water quality performance with product identification remaining flat, while Xylem sees steady growth in infrastructure and measurement, with profitability gradually improving through acquisition integration.

  • Headwind Scenario: Large-scale projects are delayed due to shrinking public budgets or persistently high interest rates. PQI (Veralto) and pump demand (Xylem), which are dependent on capital expenditure, stagnate. Acquisition integration costs put pressure on profits.

⑧ Reasons why the author is slightly more focused on Veralto

1. High Capital Efficiency and Profit Margins

With a high-margin model centered on consumables and analysis, both ROE and operating margins stand out within the water sector. Another feature is the low dividend payout ratio, which leaves significant room to allocate capital toward reinvestment and acquisitions.

2. Regulatory Tailwinds and Switching Costs

As water quality regulations, such as those for PFAS, tighten, the need to "measure accurately" will structurally increase. The lock-in effect created by reagents and consumables provides a stable revenue stream that is less susceptible to economic fluctuations.

3. Danaher-Style Serial Acquisition Model

The disciplined approach of accumulating small-to-mid-sized bolt-on acquisitions is a proven growth engine. In-Situ and GlobalVision are examples of this.

Alternative Perspectives and Counterarguments (The Appeal of Xylem)

  • Xylem's business scale is approximately 1.6 times larger, and its reach across the socially essential domain of water infrastructure is overwhelming.

  • The early completion of the Evoqua integration and a $1.5 billion share buyback demonstrate a commitment to improving profitability and returning value to shareholders.

  • Its alignment with long-term, stable demand for public infrastructure investment is stronger than Veralto's. If profit margins improve, the outlook could change significantly.

⑨ Competitive Map of Both Companies (6 Firms)

  • Direct Competitors: Pentair (PNR) / Ecolab (ECL) ... Both are major US companies that overlap in the water treatment and water quality sectors.

  • Broad Competitors: Watts Water Technologies (WTS) / IDEX (IEX) ... Their domains intersect in fluid control, pumps, and valves.

  • International or Alternative Competitors: Veolia Environnement (VIE, France) / Kurita Water Industries (6370, Japan) ... Overseas/Asian players in water treatment and water management.

⑩ Respective Risk Factors

  • Veralto's Risks: Product Quality and Innovation (PQI) is susceptible to capital expenditure trends, making growth prone to slowing down. Growth dependent on acquisitions carries the risk of integration failure or overpaying. As it has a short history since its spin-off, its track record of independent capital allocation is still in the building phase.

  • Xylem's Risks: Profit margins may struggle to grow due to commodity competition in areas like pumps. Performance is easily swayed by public budgets and delays in large-scale projects. Carrying "goodwill" from large acquisitions, it faces valuation pressure if profit improvements are delayed.

  • Common Risks: Interest rates, exchange rates, raw material costs, and a global slowdown in public/capital investment cycles. Given the high growth expectations for the water market as a whole, valuation adjustments are possible if those expectations are not met.

⑪ Summary by Reader Interest Axis

*This does not constitute a recommendation for any specific investment action.

  • Growth-Oriented: Xylem captures the breadth of water infrastructure renewal and digital measurement, while Veralto accumulates high-margin areas. The choice depends on your preference for the "quality" of growth.

  • Stability-Oriented: Veralto has sticky revenue from regulations and consumables, while Xylem has stable demand due to its close ties to public infrastructure. Both offer defensive characteristics.

  • Dividend-Oriented: Currently, Xylem's yield exceeds Veralto's (approx. 1.4% vs. approx. 0.6%). However, neither company is a high-dividend play.

  • Value-Oriented: Both companies have similar forward P/E ratios of around 20x, but Xylem has a higher trailing P/E. Evaluation should also consider the differences in how their ROE is generated.

⑫ The intrigue of this comparison

It is rare to find two companies that share the same "water" theme yet have such contrasting ways of engaging with it. Veralto, which "measures and protects quality," and Xylem, which "transports and treats," differ in where they earn their profits along the water infrastructure value chain—from upstream measurement to downstream treatment—which defines the very nature of their businesses.

  • Veralto's Core: A niche-focused model with high margins and high capital efficiency driven by analytical instruments and consumables. Through continuous acquisitions in the Danaher tradition, it targets "resilient demand" rooted in regulations and quality assurance.

  • Xylem's Core: A comprehensive water infrastructure company bundling pumps, treatment, measurement, and services. The integration of Evoqua has raised its scale, allowing it to stay closely aligned with long-term demand for public investment and digitalization. Room for margin improvement represents its growth potential.

Record Data

  • Record Date: July 18, 2026

  • Veralto (VLTO): Stock price approx. $91.5, Market cap approx. $22 billion, Forward P/E approx. 21x, ROE approx. 36.5%, Dividend yield approx. 0.6%

  • Xylem (XYL): Stock price approx. $121.4, Market cap approx. $28.9 billion, Forward P/E approx. 21x, ROE approx. 8.7%, Dividend yield approx. 1.4%, P/B ratio approx. 2.4x

  • Both companies: NYSE listed, USD denominated, December fiscal year-end, US GAAP

Sources of Figures

  • Each company's Q1 2026 earnings (Veralto Q1 2026, Xylem Q1 2026) and full-year guidance

  • Each company's 2025 full-year earnings (Veralto revenue approx. $5.5 billion, Xylem revenue approx. $9.0 billion)

  • Stock price and valuation metrics: StockAnalysis / Morningstar / Company IR (around the record date)

  • Market size: Fortune Business Insights (Water and Wastewater Treatment Market, 2025–2034, CAGR approx. 7.5%), BCC Research (Water and Wastewater Treatment Technology Market, 2025–2030, CAGR approx. 11.0%)

  • Competitor information: Various industry analyses and IR materials

Recommended Reading

Kurita Water Industries vs. Veolia — A Thorough Comparison of Business Growth Potential

Cintas vs. Ecolab — A Thorough Comparison of Business Growth Potential


A Request

If you found this article interesting, please give it a "like" or follow me, as it encourages me to keep writing. I also welcome requests for comparisons of stocks you would like me to cover.

Important Matters (Disclaimer)

This article is not intended to recommend the buying or selling of specific stocks or any investment actions; it is provided for informational purposes to help understand business operations and market environments. The content may contain the author's interpretations or errors, and I do not guarantee its accuracy or completeness. Please make final investment decisions based on your own responsibility and research.

Bonus: Today's Terminology Explained

What is "ROE (Return on Equity)"?
It is a percentage that shows how much profit a company generated in a year using its "own money (shareholder equity)." For example, if you make 10 yen in profit from 100 yen of your own capital, the ROE is 10%. However, since the figure can look high if the company has increased its debt or has little capital, it is important to look at "why it is high."

いいなと思ったら応援しよう!

kabutabi 応援ありがとうございます!情報収集に活用させていただきます!

この記事は noteマネー にピックアップされました

noteマネーのバナー